Media stories about Aethlon Medical (NASDAQ:AEMD) have trended positive recently, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aethlon Medical earned a media sentiment score of 0.27 on Accern’s scale. Accern also gave headlines about the medical equipment provider an impact score of 46.2986306775202 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Several analysts have recently commented on AEMD shares. HC Wainwright started coverage on shares of Aethlon Medical in a research note on Monday, November 20th. They set a “buy” rating and a $3.00 price target on the stock. ValuEngine cut shares of Aethlon Medical from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 11th.

Aethlon Medical (NASDAQ AEMD) traded down $0.05 on Thursday, hitting $1.43. 167,940 shares of the stock traded hands, compared to its average volume of 693,079. Aethlon Medical has a twelve month low of $0.79 and a twelve month high of $5.17. The company has a debt-to-equity ratio of 0.18, a current ratio of 17.03 and a quick ratio of 17.03. The company has a market capitalization of $20.48, a PE ratio of -2.20 and a beta of 2.26.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings results on Thursday, February 1st. The medical equipment provider reported ($0.08) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.11) by $0.03. The company had revenue of $0.08 million for the quarter, compared to the consensus estimate of $0.08 million. sell-side analysts anticipate that Aethlon Medical will post -0.52 EPS for the current fiscal year.

WARNING: This article was originally published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/02/08/favorable-news-coverage-somewhat-unlikely-to-impact-aethlon-medical-aemd-stock-price.html.

About Aethlon Medical

Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.

Insider Buying and Selling by Quarter for Aethlon Medical (NASDAQ:AEMD)

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.